Dr. Vasiliauskas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center
8730 Alden Dr. Suite 2E
Los Angeles, CA 90048Phone+1 310-423-4100Fax+1 310-423-0146
Summary
- Dr. Eric Vasiliauskas, frequently referred to as “Dr. V”, is the director of the Cedars-Sinai Nutrition & Integrative IBD Multidisciplinary Subspecialty Program, the Associate Clinical Director of the Inflammatory Bowel Disease Center at Cedars-Sinai, a member of the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, & Professor of Medicine & Pediatrics at the David Geffen School of Medicine at the University of California Los Angeles (UCLA).
Dr. V is an internationally-recognized expert in both Adult & Pediatric Inflammatory Bowel Disease who has long recognized the existence of subgroups within Crohn’s disease and ulcerative colitis and how these important subtleties influence disease expression, disease course, responses to traditional medical and surgical interventions, as well as to dietary and other alternative approaches. He has thus been a longtime proponent of personalized medicine & individualized therapy in IBD.
Dr. V has been described as “a diet-friendly doctor” and is a strong advocate of living a healthy lifestyle that incorporates routine exercise, relaxation & stress management techniques (mindfulness practices, meditation, biofeedback, yoga, etc), getting adequate sleep, & eating a balanced healthy diet. He recognizes the significant potential benefits of both traditional and nontraditional approaches to IBD care, while at the same time also acknowledging the shortcomings of each approach practiced in isolation. Throughout his career, Dr. Vasiliauskas has been open to incorporating a broad spectrum of nontraditional options to help patients fine-tune their health to wellness. He is a firm believer that a complementary or integrative approach to IBD management optimizes desired outcomes, well-being and quality of life.
Education & Training
- Inflammatory Bowel Disease Center, Cedars-Sinai Medical CenterGastroenterology Subspecialty Fellow in Inflammatory Bowel Disease, 1995 - 1996
- Inflammatory Bowel Disease Center, Cedars-Sinai Medical CenterClinical Research Fellow in Inflammatory Bowel Disease, 1994 - 1995
- Cedars-Sinai Medical Center, Harbor-UCLA, & Martin Luther King, Jr. / Charles R. Drew Medical CenterPediatric Gastroenterology, Hepatology, & Nutrition 2nd & 3rd Year Fellowship, 1993 - 1995
- Children's Hospital Los Angeles (CHLA)Pediatric Gastroenterology, Hepatology, & Nutrition 1st Year Fellowship, 1992 - 1993
- Children's Hospital Los AngelesResidency, Pediatrics, 1989 - 1991
- Children's Hospital Los AngelesInternship, Pediatrics, 1988 - 1989
- University of Illinois College of Medicine at RockfordDoctor of Medicine - MD, 1985 - 1988
- University of Illinois College of MedicineClass of 1988
- University of Illinois College of Medicine at Urbana-ChampaignDoctor of Medicine - MD, 1984 - 1985
- University of Illinois at Champaign-UrbanaBachelor of Science - BS, 1982 - 1984
- College of DuPageAssociate in Science, 1980 - 1982
- College of Du PageAssociate of Arts, 1980 - 1982
- Glenbard South High SchoolValedictorian, 1977 - 1980
- Cedars-Sinai Medical CenterFellowship, Gastroenterology
Certifications & Licensure
- CA State Medical License 1990 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease Start of enrollment: 2005 May 01
Publications & Presentations
PubMed
- 14 citationsHypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.Gaurav Syal, Lori Robbins, Amir H. Kashani, Nirupama Bonthala, Edward J. Feldman
Digestive Diseases and Sciences. 2021-01-01 - 95 citationsNOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.Shane M. Devlin, Huiying Yang, Andrew Ippoliti, Kent D. Taylor, Carol J. Landers
Gastroenterology. 2007-02-01 - 354 citationsAntibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.Stephan R. Targan, Carol J. Landers, Huiying Yang, Michael J. Lodes, Yingzi Cong
Gastroenterology. 2005-06-01
Grant Support
- Pediatric Anti TNFNational Center For Research Resources1999–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: